Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous ascorbic acid plus tranexamic acid for anemia in hemodialysis patients
TCTR20240512004Phase 0Unknown
- Sponsor
- Buriram Hospital
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 0, randomised, open-label trial of ascorbic acid and tranexamic acid in anaemia and kidney failure (2 arms), sponsored by Buriram Hospital. Primary endpoints: Serum iron, Ferritin and 3 more. Status: unknown.
02
Drugs
ascorbic acidtranexamic acid
03
Conditions
anaemiakidney failure
Beyond the preview
Go deeper on TCTR20240512004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240512004.